Forsteo Is the First Bone Formation Agent Approved for Marketing Across All Member States of The European Union Lilly (NYSE:LLY) announced today that the European Commission has granted a marketing ...
A biosimilar to Eli Lilly’s Forsteo, biosimilar teriparatide, has been launched across Europe by Gedeon Richter following the patent expiration of the reference product. A biosimilar to Eli Lilly’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results